Cubist Pharmaceuticals CEO Michael Bonney: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses the regulatory climate for anti-infectives and Cubist’s development plans following the successful launch of Cubicin.